8.99
Fulcrum Therapeutics Inc Borsa (FULC) Ultime notizie
How supply chain issues affect Fulcrum Therapeutics Inc. stock2025 Breakouts & Breakdowns & Safe Capital Growth Plans - Trung tâm Dự báo KTTV quốc gia
Will Fulcrum Therapeutics Inc. stock outperform value stocksJuly 2025 Fed Impact & Low Risk High Reward Trade Ideas - Trung tâm Dự báo KTTV quốc gia
Can momentum traders help lift Fulcrum Therapeutics Inc.July 2025 Drop Watch & High Return Trade Opportunity Guides - newser.com
Real time alert setup for Fulcrum Therapeutics Inc. performance2025 Valuation Update & AI Based Buy and Sell Signals - newser.com
How institutional buying supports Fulcrum Therapeutics Inc. stock2025 Analyst Calls & Safe Entry Point Identification - newser.com
Fulcrum Therapeutics Inc. stock volume spike explained2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com
How to track smart money flows in Fulcrum Therapeutics Inc.2025 Top Gainers & High Win Rate Trade Tips - newser.com
How to monitor Fulcrum Therapeutics Inc. with trend dashboardsBear Alert & AI Powered Buy and Sell Recommendations - newser.com
What risks investors should watch in Fulcrum Therapeutics Inc. stockRate Hike & Reliable Price Breakout Signals - newser.com
Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025 - The Manila Times
Fulcrum Therapeutics Presents Preclinical Data for FTX-6274 as a Potential Treatment for Castration-Resistant Prostate Cancer - Quiver Quantitative
Pattern recognition hints at Fulcrum Therapeutics Inc. upsideJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com
FTX-6274 Poster 2504P: Fulcrum Shows Preclinical Efficacy in CRPC at ESMO Congress Oct 18, 2025 - Stock Titan
Fulcrum Therapeutics Inc. stock outlook for YEAR2025 Technical Overview & Fast Momentum Stock Entry Tips - newser.com
Analysts Set Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Price Target at $9.60 - Defense World
Is Fulcrum Therapeutics Inc. stock poised for growthTrend Reversal & Low Risk Entry Point Guides - newser.com
How to build a dashboard for Fulcrum Therapeutics Inc. stock2025 Short Interest & Reliable Price Action Trade Plans - newser.com
What data driven models say about Fulcrum Therapeutics Inc.’s futureWeekly Stock Analysis & AI Driven Stock Movement Reports - newser.com
What is Leerink Partnrs' Estimate for FULC FY2027 Earnings? - MarketBeat
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Leerink Partnrs Has Negative Outlook of FULC FY2027 Earnings - Defense World
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq - MSN
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
47,450 Options: Fulcrum Therapeutics Grants Inducement Awards at $9.50 with 10‑Year Term - Stock Titan
Detecting price anomalies in Fulcrum Therapeutics Inc. with AIIPO Watch & Low Drawdown Investment Strategies - newser.com
What moving averages say about Fulcrum Therapeutics Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
Order flow analysis tools used on Fulcrum Therapeutics Inc.2025 Short Interest & Daily Profit Focused Screening - newser.com
Can Fulcrum Therapeutics Inc. recover in the next quarterProduct Launch & High Return Stock Watch Alerts - newser.com
Fulcrum Therapeutics Inc. stock momentum explainedQuarterly Profit Report & Fast Gain Swing Trade Alerts - newser.com
Fulcrum Therapeutics (NASDAQ:FULC) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Fulcrum Therapeutics (NASDAQ:FULC) Reaches New 12-Month HighHere's What Happened - MarketBeat
Fulcrum Therapeutics, Inc. $FULC Shares Sold by Matisse Capital - MarketBeat
What does recent volatility data suggest for Fulcrum Therapeutics Inc.July 2025 Trends & Community Consensus Picks - newser.com
Technical analysis overview for Fulcrum Therapeutics Inc. stockTrade Ideas & Growth Focused Entry Reports - newser.com
Published on: 2025-10-05 20:19:33 - newser.com
Is Fulcrum Therapeutics Inc. stock trading near support levelsRate Cut & Safe Capital Growth Stock Tips - newser.com
Using flow based indicators on Fulcrum Therapeutics Inc.Trade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Fulcrum Therapeutics Inc. recovery potential after sell offInflation Watch & Safe Entry Point Identification - newser.com
What earnings revisions data tells us about Fulcrum Therapeutics Inc.Weekly Stock Report & Fast Moving Stock Watchlists - newser.com
Can Fulcrum Therapeutics Inc. stock sustain market leadershipJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):